KRISTIN NIKOLAKEAS: Open Payments
NPI 1336342799 · BURTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,327 in 240 payments from 38 companies in 2025. Trend: 2023 $3,214 · 2024 $4,021 · 2025 $4,327
Food & beverage: $4,314Education: $14
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $406 |
| ABBVIE INC. | 32 | $336 |
| HARMONY BIOSCIENCES LLC | 11 | $336 |
| Amgen Inc. | 18 | $291 |
| Lundbeck LLC | 17 | $276 |
| Vanda Pharmaceuticals Inc. | 18 | $269 |
| Otsuka America Pharmaceutical, Inc. | 15 | $266 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $236 |
| PFIZER INC. | 15 | $195 |
| Novo Nordisk Inc | 10 | $188 |
Products named: REXULTI, WAKIX, FANAPT, AIRSUPRA, CAPLYTA, NURTEC ODT, XIFAXAN, INGREZZA.
Industry payments across MI — which companies pay providers there.
